Literature DB >> 17557516

Minimally invasive radioguided surgery for parathyroid adenomas (MIRP).

S P Somashekhar1, P Gupta, S Ballal, S S Zaveri, K V Udupa.   

Abstract

BACKGROUND: Parathyroid adenoma is the most common cause of primary hyperparathyroidism. Conventional surgical management includes bilateral neck exploration with removal of the adenoma(s) and biopsy of one of the other glands with visualization of all glands. It is associated with a risk of permanent hypoparathyroidism. Radioguided excision of parathyroid adenoma is a widely accepted technique which provides accurate localization and complete excision of the lesion with low morbidity. We report our experience with this technique.
METHODS: We performed radioguided excision of parathyroid adenomas in 15 patients. All of them had preoperative localization of the adenoma using a dual tracer, dual phase 99mTc-Sestamibi scan. A dose of 8-10 mCi of 99mTc-Sestamibi was injected intravenously 2 hours before surgery. Under local anaesthesia, surgical excision of the lesion was done after localizing it using a hand-held gamma probe. Complete excision was confirmed by frozen. section of the excised lesion and an intraoperative quick parathormone assay.
RESULTS: The 99mTc-Sestamibi scan revealed an increased uptake by the adenoma in all patients and complete excision was possible in all the patients. Frozen section confirmed the diagnosis and the quick parathormone assay (within 15 minutes) revealed a drop in parathormone levels to < 50% after excision in all of them. Three patients developed hypocalcaemia postoperatively and were treated with intravenous calcium supplementation. At a follow up of 2-29 months, all the patients were normocalcaemic. The renal functions improved in 2 of 6 patients who had renal failure.
CONCLUSION: Minimally invasive radioguided excision of parathyroid adenomas is a simple, safe and effective technique associated with a low morbidity and can be done as a day-care procedure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557516

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  3 in total

1.  Sestamibi (99mTc) scan as a single localization modality in primary hyperparathyroidism and factors impacting its accuracy.

Authors:  Yousof Alabdulkarim; Edgard Nassif
Journal:  Indian J Nucl Med       Date:  2010-01

Review 2.  Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.

Authors:  Naykky M Singh Ospina; Rene Rodriguez-Gutierrez; Spyridoula Maraka; Ana E Espinosa de Ycaza; Sina Jasim; Ana Castaneda-Guarderas; Michael R Gionfriddo; Alaa Al Nofal; Juan P Brito; Patricia Erwin; Melanie Richards; Robert Wermers; Victor M Montori
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

Review 3.  Use of (99m)Tc 2-methoxyisobutyl isonitrile in minimally invasive radioguided surgery in patients with primary hyperparathyroidism: A narrative review of the current literature.

Authors:  Kristie A Denmeade; Chris Constable; Warren M Reed
Journal:  J Med Radiat Sci       Date:  2013-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.